Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure (Q73943124)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(97)00722-4

28 November 2024

1 reference

F H Messerli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E. Grossman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9399721

28 November 2024

language of work or name

English

0 references

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

8 November 2019

https://api.elsevier.com/content/article/PII:S0002914997007224?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(97)00722-4

https://api.elsevier.com/content/article/PII:S0002914997007224?httpAccept=text/plain

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(97)00722-4

American Journal of Cardiology

28 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

1453-1458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

The hemodynamic link between insulin resistance and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Epinephrine-induced insulin resistance in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Relevance of 24 H blood pressure profile and sympathetic activity for outcome on short- versus long-acting 1,4-dihydropyridines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Autonomic nervous system and sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Influence of Catecholamines on Nucleotide-induced Platelet Aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Some Effects of Adrenaline and Anti-Adrenaline Compounds on Platelets in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Cardiovascular effects of verapamil in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Acute and Chronic Effects of Nifedipine on Plasma Renin Activity and Plasma Adrenaline and Noradrenaline in Controls and Hypertensive Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

The effects of nifedipine and hydralazine induced hypotension on sympathetic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

β-Adrenergic Receptors and Reflex Tachycardia After Single and Repeated Felodipine Administration in Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Catecholamines, renin-angiotensin-aldosterone, and cardiovascular response during exercise following acute and long-term calcium antagonism with felodipine in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Treatment of essential hypertension with felodipine in combination with a diuretic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Effects of hydrochlorothiazide and diltiazem on reflex vasoconstriction in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Lack of effect of nifedipine on counterregulatory mechanisms in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900722-4

Sympathetic nervous system activity and the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(97)00722-4

Relation of plasma norepinephrine and sympathetic traffic during hypotension in humans

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(97)00722-4

Effects of nifedipine on blood pressure, regional hemodynamics, plasma renin activity and plasma catecholamines in patients with arterial hypertension

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(97)00722-4

Hypotensive effect of nifedipine in hypertensive patients with chronic renal failure

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(97)00722-4

28 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399721%20AND%20SRC:MED&resulttype=core&format=json